Request Information
Request Information
The MONARCH® Platform integrates the latest advancements in robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to improve outcomes and reduce cost.
Listen to Dr. Paul Chomiak share his experience incorporating the MONARCH® Platform into his thoracic surgery practice.
Dr. Fred Moll, a leader and pioneer in the field of medical robotics, founded Auris Health with a vision to transform medical intervention. Johnson & Johnson (J&J) acquired Auris Health in 2019 & Verb Surgical in 2020 to accelerate innovation in the robotics space.
As part of the J&J Family of Companies, Auris is collaborating with the Lung Cancer Initiative that leverages J&J's collective expertise to change the trajectory of lung cancer.
Lung cancer is the # 1 cancer killer – claiming more victims each year than breast, colon and prostate cancers combined. During the early stage of lung cancer, diagnosing small, peripheral nodules safely can be very difficult. Auris' goal is to help physicians overcome the challenges they face when biopsying small, peripheral lung nodules.
The Impact of Monarch® Platform
The MONARCH® Platform integrates a variety of technologies designed to empower physicians with greater reach, uninterrupted vision, and meticulous control. The MONARCH Platform maintains vision throughout the procedure, especially during the most critical step - the biopsy.
The Impact of Monarch Robotics